The microsatellite DNA abnormity shows no evident difference to clinic stage and pathology type in lung cancer patients (P >0. 05) .

• 在肺癌组中；各个微卫星位点的异常表现与肺癌临床分期和临床病理类型之间无明显差异(P>0.；05)。